{"DataElement":{"publicId":"2181820","version":"1","preferredName":"Medulloblastoma Tumor Clinical M Stage","preferredDefinition":"the M Stage according to Chang staging system for medulloblastoma trials only.","longName":"MEDULLO_TUMOR_C_M_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188971","version":"1","preferredName":"Medulloblastoma Tumor Clinical M Stage","preferredDefinition":"information related to clinical M stage of a medulloblastoma brain tumor.","longName":"MEDULLO_TUMOR_C_M","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2660463","version":"1","preferredName":"Medulloblastoma Neoplasm","preferredDefinition":"A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3222:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-ECD4-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5CB24DC-8621-3F9E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181821","version":"1","preferredName":"Brain Tumor M Stage","preferredDefinition":"the metastasis stage for brain tumors based on the Chang staging system.","longName":"BRAIN_TUMOR_M_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MX","valueDescription":"MX","ValueMeaning":{"publicId":"2568674","version":"1","preferredName":"MX","longName":"2568674","preferredDefinition":"MX","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D94F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5C5B26F-9B9A-2950-E034-0003BA12F5E7","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M0","valueDescription":"M0","ValueMeaning":{"publicId":"2568675","version":"1","preferredName":"M0","longName":"2568675","preferredDefinition":"M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D950-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5C5B26F-9B9E-2950-E034-0003BA12F5E7","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M1","valueDescription":"M1","ValueMeaning":{"publicId":"2568257","version":"1","preferredName":"M1","longName":"2568257","preferredDefinition":"M1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7AE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5C5B26F-9BA1-2950-E034-0003BA12F5E7","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M2","valueDescription":"M2","ValueMeaning":{"publicId":"2568258","version":"1","preferredName":"M2","longName":"2568258","preferredDefinition":"M2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7AF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5C5B26F-9BA4-2950-E034-0003BA12F5E7","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M3","valueDescription":"M3","ValueMeaning":{"publicId":"2568259","version":"1","preferredName":"M3","longName":"2568259","preferredDefinition":"M3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5C5B26F-9BA7-2950-E034-0003BA12F5E7","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M4","valueDescription":"M4","ValueMeaning":{"publicId":"2568676","version":"1","preferredName":"M4","longName":"2568676","preferredDefinition":"M4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D951-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5C62D7E-17D8-293F-E034-0003BA12F5E7","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M0 or M1","valueDescription":null,"ValueMeaning":{"publicId":"14216924","version":"1","preferredName":"Stage M0 Or Stage M1","longName":"14216924v1.00","preferredDefinition":"A stage term that refers to central nervous system embryonal tumor or ependymoma in which no visible tumor is detected beyond the primary site of disease on MRI imaging (brain and spine) and no tumor cells are found in the CSF._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A stage term that refers to central nervous system embryonal tumor or ependymoma in which tumor cells are present in the CSF.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage M0","conceptCode":"C198463","definition":"A stage term that refers to central nervous system embryonal tumor or ependymoma in which no visible tumor is detected beyond the primary site of disease on MRI imaging (brain and spine) and no tumor cells are found in the CSF.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage M1","conceptCode":"C198464","definition":"A stage term that refers to central nervous system embryonal tumor or ependymoma in which tumor cells are present in the CSF.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"018FB7A5-C315-7772-E063-731AD00A6650","latestVersionIndicator":"Yes","beginDate":"2023-07-28","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-28","modifiedBy":"LISU","dateModified":"2023-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"018FB7A5-C316-7772-E063-731AD00A6650","beginDate":"2023-07-28","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-28","modifiedBy":"LISU","dateModified":"2023-07-28","deletedIndicator":"No"},{"value":"Localized","valueDescription":null,"ValueMeaning":{"publicId":"2561814","version":"1","preferredName":"Localized","longName":"2561814","preferredDefinition":"Restricted to the site of origin, without evidence of spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Localized","conceptCode":"C14146","definition":"Restricted to the site of origin, without evidence of spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE83-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-09","modifiedBy":"CURTIST","dateModified":"2009-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"018FB7A5-C317-7772-E063-731AD00A6650","beginDate":"2023-07-28","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-28","modifiedBy":"LISU","dateModified":"2023-07-28","deletedIndicator":"No"},{"value":"Metastatic","valueDescription":null,"ValueMeaning":{"publicId":"2561250","version":"1","preferredName":"Metastatic","longName":"2561250","preferredDefinition":"Having to do with metastasis, which is the spread of cancer from the primary site (place where it started) to other places in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BC4F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-05-16","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-05-16","modifiedBy":"REEVESD","dateModified":"2014-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"018FB7A5-C318-7772-E063-731AD00A6650","beginDate":"2023-07-28","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-28","modifiedBy":"LISU","dateModified":"2023-07-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C62D7E-17D2-293F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"LISU","dateModified":"2023-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Chang M Stage","type":"Preferred Question Text","description":"Chang M Stage","url":null,"context":"CTEP"}],"origin":"Brain CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5C5E205-799F-2D22-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-16","modifiedBy":"REEVESD","dateModified":"2011-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}